Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial.
Wei J, Lu X, Liu Q, Fu Y, Liu S, Zhao Y, Zhou J, Chen H, Wang M, Li L, Yang J, Liu F, Zheng L, Yin H, Yang Y, Zhou C, Zeng P, Zhou X, Ding N, Chen S, Zhao X, Yan J, Fan X, Guan W, Liu B.
Wei J, et al.
Nat Commun. 2023 Aug 14;14(1):4904. doi: 10.1038/s41467-023-40480-x.
Nat Commun. 2023.
PMID: 37580320
Free PMC article.
Clinical Trial.